Long-term safety and effectiveness of mixed amphetamine salts extended release in adults with ADHD.

@article{Biederman2005LongtermSA,
  title={Long-term safety and effectiveness of mixed amphetamine salts extended release in adults with ADHD.},
  author={Joseph Biederman and Thomas J. Spencer and Timothy E Wilens and Richard H. Weisler and Stephanie C Read and Simon J Tulloch},
  journal={CNS spectrums},
  year={2005},
  volume={10 12 Suppl 20},
  pages={16-25}
}
OBJECTIVE Assess the long-term safety and effectiveness of mixed amphetamine salts extended release (MAS XR) in adults with attention-deficit/hyperactivity disorder (ADHD) combined subtype. METHODS A 24-month, open-label extension of a 4-week, multicenter, double-blind, placebo-controlled, parallel-group, forced-dose-escalation study of MAS XR in adults (>or=18 years of age) with ADHD. The 223 enrolled subjects started treatment at 20 mg/day for 1 week, with subsequent titration up to 60 mg… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 22 extracted citations

Similar Papers

Loading similar papers…